Documents
Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 100MCG/0.5ML | 0 | KIMMTRAK | TEBENTAFUSP-TEBN |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2022-01-25 | PRIORITY |
LABELING; Labeling | SUPPL | 2 | AP | 2022-11-29 | STANDARD |
Submissions Property Types
CDER Filings
IMMUNOCORE LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 761228
[companyName] => IMMUNOCORE LTD
[docInserts] => ["",""]
[products] => [{"drugName":"KIMMTRAK","activeIngredients":"TEBENTAFUSP-TEBN","strength":"100MCG\/0.5ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"01\/25\/2022","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/761228s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"01\/25\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/761228s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2022\\\/761228Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2022-01-25
)
)